Fujirebio Diagnostics

Fujirebio Diagnostics is a leader in cancer biomarker assays and in vitro diagnostics. Their products support early detection and monitoring of disease, aiding clinicians in making informed treatment decisions.

All by Fujirebio Diagnostics

Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G ?-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
| 2 min read
Page 1 of 1 - 1 Total Items

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image